CCA
ZYNE

Cruiser Capital Advisors’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Cruiser Capital Advisors’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-36,888
Closed -$301K – 41
2018
Q3 		$301K Buy
36,888
+4,000
+12% +$32.6K 0.15% 30
2018
Q2 		$320K Sell
32,888
-6,387
-16% -$62.1K 0.15% 22
2018
Q1 		$341K Hold
39,275
– – 0.22% 23
2017
Q4 		$492K Buy
+39,275
New +$492K 0.38% 20